Pharmacokinetics and Pharmacodynamics of Atazanavir-containing Antiretroviral Regimens, with or without Ritonavir, in Patients who are HIV-positive and Treatment-naïve-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics of Atazanavir-containing Antiretroviral Regimens, with or without Ritonavir, in Patients who are HIV-positive and Treatment-naïve

Published:2013-03 Issue:3 Volume:33 Page:284-294
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Bertz Richard J.¹,Persson Anna¹,Chung Ellen¹,Zhu Li¹,Zhang Jenny¹,McGrath Donnie²,Grasela Dennis¹

Affiliation:

1. Bristol-Myers Squibb; Research and Development; Princeton New Jersey

2. Wallingford Connecticut

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1205/fullpdf

Reference31 articles.

1. Atazanavir: simplicity and convenience in different scenarios;Perez-Elias;Expert Opin Pharmacother,2007

2. Atazanavir: a review of its use in the management of HIV infection;Swainston;Drugs,2005

3. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents 2012 http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf

4. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel;Hammer;JAMA,2008

5. Bristol-Meyers Squibb Princeton, NJ 2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of potency and metabolic stability of diphyllin-derived Vacuolar-ATPase inhibitors;European Journal of Medicinal Chemistry;2024-09

2. Phase I study, and dosing regimen selection for a pivotal COVID-19 trial of GST-HG171;Antimicrobial Agents and Chemotherapy;2024-01-10

3. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates;Chemical Society Reviews;2024

4. A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir;Clinical Pharmacokinetics;2024-01

5. Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin;Clinical Infectious Diseases;2023-11-20